A randomised, two arm, multi-centre Gynaecologic Cancer InterGroup phase III trial of adding bevacizumab to standard chemotherapy (carboplatin and paclitaxel) in first line treatment of patients with epithelial ovarian cancer.
Trial Number
NCT00483782 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
CCTG